CHESSA, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 30.832
NA - Nord America 826
AS - Asia 244
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 31.906
Nazione #
IT - Italia 30.647
US - Stati Uniti d'America 816
CN - Cina 102
SG - Singapore 63
SE - Svezia 58
DE - Germania 36
VN - Vietnam 25
FI - Finlandia 24
UA - Ucraina 18
JP - Giappone 17
GB - Regno Unito 16
IN - India 13
CA - Canada 9
FR - Francia 7
KR - Corea 7
CZ - Repubblica Ceca 5
ID - Indonesia 5
IE - Irlanda 5
ES - Italia 4
IR - Iran 4
GR - Grecia 3
IQ - Iraq 3
EG - Egitto 2
IL - Israele 2
NL - Olanda 2
PL - Polonia 2
AT - Austria 1
AU - Australia 1
DK - Danimarca 1
JO - Giordania 1
LT - Lituania 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 31.906
Città #
Cagliari 29.172
Uta 1.336
Fairfield 105
Boardman 99
Ashburn 82
Chandler 68
Woodbridge 57
Nyköping 53
Shanghai 46
Singapore 39
Houston 37
Seattle 37
Cambridge 35
Wilmington 30
Ann Arbor 27
Helsinki 23
Dong Ket 22
Rome 22
Redwood City 18
Boston 17
Dearborn 14
Jacksonville 10
Milan 10
Munich 10
New York 8
Beijing 7
Hyderabad 6
Los Angeles 6
Nanjing 6
Seoul 6
London 5
Mountain View 5
Phoenix 5
San Diego 5
Selargius 5
Sestu 5
Toronto 5
Brno 4
Naples 4
Ponte di Piave 4
San Mateo 4
Zola Predosa 4
Baghdad 3
Burnaby 3
Dublin 3
Guangzhou 3
Hanoi 3
Jakarta 3
Laurel 3
Licata 3
San Sperate 3
St. Cloud 3
Tokyo 3
Alghero 2
Amsterdam 2
Augusta 2
Bangalore 2
Berlin 2
Buffalo 2
Bussolengo 2
Chaoyang 2
East Syracuse 2
Enna 2
Ferrara di Monte Baldo 2
Grumello Cremonese 2
Gurgaon 2
Hefei 2
Ichibacho 2
Islington 2
Jiaxing 2
Krakow 2
Leawood 2
Macomer 2
Medan 2
Nocera Umbra 2
Norwalk 2
Ossi 2
Paris 2
Pune 2
Quanzhou 2
Shenzhen 2
Usellus 2
Xi'an 2
Xiamen 2
Aarhus 1
Adachi 1
Amman 1
Ardabil 1
Changsha 1
Chapel Hill 1
Cherry Hill 1
Chicago 1
Chiswick 1
Chizhou 1
Chuocho 1
Council Bluffs 1
Dongguan 1
Durham 1
Elmas 1
Esslingen am Neckar 1
Totale 31.574
Nome #
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 2.997
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 2.861
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.438
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.229
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.169
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.076
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.420
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.390
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.255
null 1.241
Physician global assessment in systemic lupus erythematosus: Can we rely on its reliability? 1.057
Targeted Therapies in Axial Psoriatic Arthritis 1.005
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 959
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 892
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 862
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 834
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 791
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 760
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 746
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 737
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 713
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 526
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 450
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study 425
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus 340
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 303
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 219
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 158
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease 96
Structural Brain MR Imaging Alterations in Patients with Systemic Lupus Erythematosus with and without Neuropsychiatric Events 60
Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS) 51
Totale 32.060
Categoria #
all - tutte 39.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.740 0 0 0 38 975 982 434 82 56 45 33 95
2020/20215.488 114 171 182 2.032 1.015 507 311 243 150 298 298 167
2021/20222.239 146 95 121 76 150 107 137 139 192 263 450 363
2022/20233.547 363 503 387 268 260 442 198 251 232 238 259 146
2023/20246.327 108 178 215 456 550 673 590 2.199 243 224 457 434
2024/202510.201 4.007 4.241 1.249 704 0 0 0 0 0 0 0 0
Totale 32.060